Four viruses and one bacteria were responsible for 12% of the world’s cancer cases in 2024. Does this mean they’re preventable?
Articles on Epstein-Barr virus
Displaying all articles
Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment in the future.
More than 90% of adults worldwide are already infected with the Epstein-Barr virus.
Our study provides new insights into the way that immune cells which fight a common virus behave in people with MS.
A growing body of evidence suggests the main driver of MS is an abnormal immune response to Epstein-Barr virus.
People who take antiretroviral drugs have a much lower risk of getting multiple sclerosis – especially women.
We know from other viruses that viral fragments can remain in different tissues for months or even years. This could be the case for long COVID.
Recent research has shown there’s a link between multiple sclerosis and Epstein-Barr virus. A new study brings us closer to understanding the nature of this connection.
The causes of multiple sclerosis (MS) are complex, but recent research found Epstein Barr virus, the same virus that causes mononucleosis, is an environmental trigger for MS.
Fatigue can drag for weeks, even when the infection is gone, and sleep doesn’t fix it. But there are simple steps you can take to ride it out.
COVID-19 has taken away so much. An immunology researcher describes the good it may leave behind.
Some cancers are actually caused by viruses that linger for long periods in the body, or cause physical damage that later turns cancerous.
Top contributors
-
Assistant Professor, Department of Clinical Neuroscience, Karolinska Institutet
-
Associate Professor in Viral and Tumour Immunology, University of Birmingham
-
General Practitioner, PhD Candidate, Bond University
-
Senior Research Associate, Kirby Institute, UNSW
-
Senior Research Fellow, Primary Care and Population Health, UCL
-
Professor of Pathology, Vice-chair for Research, University of Miami
-
Research Fellow, Institute of Cancer and Genomic Sciences, University of Birmingham
-
Professor and Laboratory Head, The University of Melbourne
-
Associate Professor of Biomedical Informatics, University of Nebraska Omaha
-
Saskatchewan Multiple Sclerosis Clinical Research Chair and Professor of Neurology, University of Saskatchewan
-
Postdoctoral Researcher, Health Research Institute, University of Limerick
-
Associate Professor, Department of Immunology and Immunotherapy, University of Birmingham
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Clinical Senior Lecturer, Clinical Medicine, Trinity College Dublin
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)